FDG-PET metrics in advanced non-small cell lung cancer (NSCLC): a review and meta-analysis

ConclusionBaseline PET metrics are powerful prognostic factors for advanced NSCLC patients who are treated with chemotherapy or targeted therapy. Further examination of the prognostic value of PET metrics for patients who receive first-line immunotherapy is warranted.

Source: Clinical and Translational Imaging - February 9, 2023 Category: Radiology Source Type: research